Tullis Health Investors
Tullis Health Investors is a specialized healthcare investment manager focused on generating superior returns by investing in innovative healthcare technologies and services. The firm targets high-growth, scalable, commercial-stage companies that have a significant impact on global health. Tullis Health Investors leverages its extensive industry expertise and network to source and manage deals, aiming to create long-term value and improve patient outcomes worldwide.
Portfolio
electroCore is dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy, initially focused on the treatment of multiple conditions in neurology and rheumatology.
#Bioelectronic Medicine
Alphatec Holdings is dedicated to revolutionizing the approach to spine surgery through clinical distinction. The company focuses on developing new approaches that integrate seamlessly with its expanding AlphaInformatiX Platform to better inform surgery and achieve the goals of spine surgery.
#Medical Devices
TriSalus Life Sciences is focused on developing innovative therapies for the treatment of solid tumors. The company leverages its proprietary Pressure-Enabled Drug Delivery (PEDD) technology to enhance the delivery and efficacy of therapeutic agents.
#Life Sciences